Real-Time, In Vivo Molecular Monitoring Using Electrochemical Aptamer Based Sensors: Opportunities and Challenges
| Autor: | Alex M. Downs, Kevin W. Plaxco |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Fluid Flow and Transfer Processes
EAB sensors Process Chemistry and Technology Biomedical Engineering in vivo sensing Bioengineering Biosensing Techniques Electrochemical Techniques E-AB sensors Aptamers Nucleotide biosensors Aptamers electrochemical aptamer sensors electrochemical biosensing Article Analytical Chemistry Animals Nanotechnology Nucleotide Instrumentation Biotechnology |
| Zdroj: | ACS sensors, vol 7, iss 10 ACS Sens |
| ISSN: | 2379-3694 |
| DOI: | 10.1021/acssensors.2c01428 |
| Popis: | The continuous, real-time measurement of specific molecules in situ in the body would greatly improve our ability to understand, diagnose, and treat disease. The vast majority of continuous molecular sensing technologies, however, either (1) rely on the chemical or enzymatic reactivity of their targets, sharply limiting their scope, or (2) have never been shown (and likely will never be shown) to operate in the complex environments found in vivo. Against this background, here we review electrochemical aptamer-based (EAB) sensors, an electrochemical approach to real-time molecular monitoring that has now seen 15 years of academic development. The strengths of the EAB platform are significant: to date it is the only molecular measurement technology that (1) functions independently of the chemical reactivity of its targets, and is thus general, and (2) supports in vivo measurements. Specifically, using EAB sensors we, and others, have already reported the real-time, seconds-resolved measurements of multiple, unrelated drugs and metabolites in situ in the veins and solid tissues of live animals. Against these strengths, we detail the platform’s remaining weaknesses, which include still limited measurement duration (hours, rather than the more desirable days) and the difficulty in obtaining sufficiently high-performance aptamers against new targets, before then detailing promising approaches overcoming these hurdles. Finally, we close by exploring the opportunities we believe this potentially revolutionary technology (as well as a few, possibly competing technologies) will create for both researchers and clinicians. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|